Literature DB >> 30137280

Histopathological Features of Inflammatory Bowel Disease are Associated With Different CD4+ T Cell Subsets in Colonic Mucosal Lamina Propria.

Xianyong Gui1, Ji Li2,3, Aito Ueno2, Marietta Iacucci2,4, Jiaming Qian3, Subrata Ghosh2,4.   

Abstract

BACKGROUND: Inflammatory bowel disease [IBD] results particularly from an aberrance of CD4+ helper and regulatory T cells and comprises histopathologically chronic active enterocolitis with features reflecting both activity and chronicity of mucosal inflammation. The exact immunological-histological correlation in IBD is not understood.
METHODS: We studied the correlation between colonic mucosal CD4+ T cell subsets [Th1, Th2, Th17, Th22 and Treg] and mucosal histological changes in ulcerative colitis [UC] and Crohn's disease [CD]. CD4+ T cell subtyping and enumeration were achieved by flow cytometry. Histological features were categorized and assessed semi-quantitatively using three validated histological scoring schemes [ECAP, RHI and D'Haens]. Correlations between prevalence [%] of CD4+ T cell subsets and histological scores were analysed.
RESULTS: Treg cells were correlated with ECAP category A [activity] as well as RHI scores. Treg cell were increased particularly in mucosa with severe neutrophilic infiltration in the cryptal/surface epithelium and in lamina propria, and with basal plasmacytosis. Th17 cells were also increased in cases with extensive neutrophil infiltrate in lamina propria, whereas RORc+ cells were increased in cases with severe lymphoplasmacytic infiltration in lamina propria. In both UC and CD, mucosa with marked crypt architectural alteration had increased IL-22+ and Th22 cells. UC with Paneth cell metaplasia had higher Th17 cells. CD with granuloma had increased IL-22+ and IL-22+IFN-γ+ cells.
CONCLUSIONS: The Treg subset appears to be associated with the overall severity of IBD histopathology, particularly with active inflammation. Th17 is also associated with activity. By contrast, IL-22+ cells are associated with chronicity and granuloma formation in CD.

Entities:  

Mesh:

Year:  2018        PMID: 30137280     DOI: 10.1093/ecco-jcc/jjy116

Source DB:  PubMed          Journal:  J Crohns Colitis        ISSN: 1873-9946            Impact factor:   9.071


  12 in total

1.  BMSCs improve TNBS-induced colitis in rats by inducing Treg differentiation by expressing PD-L1.

Authors:  Fei Gao; Dandan Cui; Dongmei Zuo; Zhexing Shou; Jia Yang; Ting Yu; Yujin Liu; Si Chu; Feng Zhu; Chunzhu Wei
Journal:  Biotechnol Lett       Date:  2022-10-20       Impact factor: 2.716

2.  Systematic review: gastrointestinal infection and incident inflammatory bowel disease.

Authors:  Jordan E Axelrad; Ken H Cadwell; Jean-Frederic Colombel; Shailja C Shah
Journal:  Aliment Pharmacol Ther       Date:  2020-05-05       Impact factor: 8.171

Review 3.  T helper cell immunity in pregnancy and influence on autoimmune disease progression.

Authors:  Jonathon J Graham; Maria Serena Longhi; Michael A Heneghan
Journal:  J Autoimmun       Date:  2021-05-18       Impact factor: 7.094

Review 4.  Interplay between Cytokine Circuitry and Transcriptional Regulation Shaping Helper T Cell Pathogenicity and Plasticity in Inflammatory Bowel Disease.

Authors:  Shin-Huei Fu; Ming-Wei Chien; Chao-Yuan Hsu; Yu-Wen Liu; Huey-Kang Sytwu
Journal:  Int J Mol Sci       Date:  2020-05-11       Impact factor: 5.923

5.  Isosteviol Sodium Exerts Anti-Colitic Effects on BALB/c Mice with Dextran Sodium Sulfate-Induced Colitis Through Metabolic Reprogramming and Immune Response Modulation.

Authors:  Shanping Wang; Jiandong Huang; Fei Liu; Keai Sinn Tan; Liangjun Deng; Yue Lin; Wen Tan
Journal:  J Inflamm Res       Date:  2021-12-20

6.  Sinomenine Hydrochloride Ameliorates Fish Foodborne Enteritis via α7nAchR-Mediated Anti-Inflammatory Effect Whilst Altering Microbiota Composition.

Authors:  Jiayuan Xie; Ming Li; Weidong Ye; Junwei Shan; Xuyang Zhao; You Duan; Yuhang Liu; Bruno Hamish Unger; Yingyin Cheng; Wanting Zhang; Nan Wu; Xiao-Qin Xia
Journal:  Front Immunol       Date:  2021-11-23       Impact factor: 7.561

7.  PICaSSO Histologic Remission Index (PHRI) in ulcerative colitis: development of a novel simplified histological score for monitoring mucosal healing and predicting clinical outcomes and its applicability in an artificial intelligence system.

Authors:  Xianyong Gui; Alina Bazarova; Rocìo Del Amor; Vincenzo Villanacci; Michael Vieth; Gert de Hertogh; Davide Zardo; Tommaso Lorenzo Parigi; Elin Synnøve Røyset; Uday N Shivaji; Melissa Anna Teresa Monica; Giulio Mandelli; Pradeep Bhandari; Silvio Danese; Jose G Ferraz; Bu'Hussain Hayee; Mark Lazarev; Adolfo Parra-Blanco; Luca Pastorelli; Remo Panaccione; Timo Rath; Gian Eugenio Tontini; Ralf Kiesslich; Raf Bisschops; Enrico Grisan; Valery Naranjo; Subrata Ghosh; Marietta Iacucci
Journal:  Gut       Date:  2022-02-16       Impact factor: 23.059

8.  Polyphenolic Maqui Extract as a Potential Nutraceutical to Treat TNBS-Induced Crohn's Disease by the Regulation of Antioxidant and Anti-Inflammatory Pathways.

Authors:  Tamara Ortiz; Federico Argüelles-Arias; Matilde Illanes; Josefa-María García-Montes; Elena Talero; Laura Macías-García; Ana Alcudia; Victoria Vázquez-Román; Virginia Motilva; Manuel De-Miguel
Journal:  Nutrients       Date:  2020-06-11       Impact factor: 5.717

9.  Development of Mucosal PNAd+ and MAdCAM-1+ Venules during Disease Course in Ulcerative Colitis.

Authors:  Britt Roosenboom; Ellen G van Lochem; Jos Meijer; Carolijn Smids; Stefan Nierkens; Eelco C Brand; Liselot W van Erp; Larissa G J M Kemperman; Marcel J M Groenen; Carmen S Horjus Talabur Horje; Peter J Wahab
Journal:  Cells       Date:  2020-04-06       Impact factor: 6.600

Review 10.  Dissecting the Heterogeneity in T-Cell Mediated Inflammation in IBD.

Authors:  Irma Tindemans; Maria E Joosse; Janneke N Samsom
Journal:  Cells       Date:  2020-01-02       Impact factor: 6.600

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.